brentuximab vedotin [Brentuximab Vedotin]

tematický
42
Termíny

Adcetris
cAC10-vcMMAE
SGN-35

 

Adcetris
CAC10-1006
cAC10-vcMMAE
SGN-35

Perzistentní odkaz   https://www.medvik.cz/link/D000079963
Definice

Imunokonjugát složený z konjugátu chimerické monoklonální protilátky cAC-10 (namířené proti antigenu CD30) a monomethyl auristatinu E. Používá se k léčbě lymfomu.

Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA.

DUI
D000079963 MeSH Prohlížeč
CUI
M0551563
Historická pozn.
2020 (2010)
Veřejná pozn.
2020; BRENTUXIMAB VEDOTIN was indexed under IMMUNOCONJUGATES 2010-2019

Povolená podhesla

AN
analýza
AD
aplikace a dávkování 6
BI
biosyntéza
CH
chemie
HI
dějiny
EC
ekonomika
PK
farmakokinetika
PD
farmakologie 7
PH
fyziologie
GE
genetika
IM
imunologie
IP
izolace a purifikace
CL
klasifikace
BL
krev
ME
metabolismus
UR
moč
CF
mozkomíšní mok
PO
otrava
AE
škodlivé účinky 3
TU
terapeutické užití 20
TO
toxicita 1
DE
účinky léků
RE
účinky záření
UL
ultrastruktura

D Chemikálie a léčiva
D12 aminokyseliny, peptidy a proteiny 16
D12.644 peptidy 1 383
D12.644.456 oligopeptidy 325
D12.644.456.050 amanitiny 30
D12.644.456.073 angiotensiny 181
D12.644.456.120 antipain
D12.644.456.157 atazanavir sulfát 5
D12.644.456.193 bradykinin 101
D12.644.456.217 brentuximab vedotin 42
D12.644.456.241 ceruletid 10
D12.644.456.270 chalony 13
D12.644.456.300 peptid vyvolávající delta spánek 1
D12.644.456.345 dipeptidy 143
D12.644.456.400 N-formylmethionin-leucyl-fenylalanin 5
D12.644.456.448 glutathion 538
D12.644.456.460 hormon uvolňující gonadotropiny 321
D12.644.456.580 leupeptiny 11
D12.644.456.650 netropsin 4
D12.644.456.716 pentagastrin 23
D12.644.456.724 pepstatiny 9
D12.644.456.726 peptichemio
D12.644.456.729 peptid T
D12.644.456.735 faloidin 17
D12.644.456.800 tachykininy 9
D12.644.456.805 technecium 99mTc mertiatid 7
D12.644.456.810 teprotid
D12.644.456.830 tetragastrin
D12.644.456.835 thymový humorální faktor 5
D12.644.456.837 hormon uvolňující thyreotropin 172
D12.644.456.840 tuftsin 5
D12.644.456.925 vasopresiny 510
D12.776 proteiny 2 581
D12.776.124 krevní proteiny 909
D12.776.124.486 imunoproteiny 14
D12.776.124.486.485 imunoglobuliny 1 492
D12.776.124.486.485.114 protilátky 1 815
D12.776.124.486.485.114.224 monoklonální protilátky 4 659
D12.776.124.486.485.114.224.060 humanizované monoklonální protilátky 2 854
D12.776.124.486.485.114.224.060.125 abciximab 14
D12.776.124.486.485.114.224.060.250 adalimumab 349
D12.776.124.486.485.114.224.060.313 alemtuzumab 125
D12.776.124.486.485.114.224.060.344 basiliximab 2
D12.776.124.486.485.114.224.060.375 bevacizumab 452
D12.776.124.486.485.114.224.060.438 brentuximab vedotin 42
D12.776.124.486.485.114.224.060.500 certolizumab pegol 47
D12.776.124.486.485.114.224.060.750 cetuximab 186
D12.776.124.486.485.114.224.060.766 daklizumab 6
D12.776.124.486.485.114.224.060.782 denosumab 153
D12.776.124.486.485.114.224.060.790 gemtuzumab 16
D12.776.124.486.485.114.224.060.794 inotuzumab ozogamicin 12
D12.776.124.486.485.114.224.060.798 ipilimumab 263
D12.776.124.486.485.114.224.060.813 natalizumab 157
D12.776.124.486.485.114.224.060.829 nivolumab 449
D12.776.124.486.485.114.224.060.844 omalizumab 112
D12.776.124.486.485.114.224.060.860 palivizumab 12
D12.776.124.486.485.114.224.060.864 panitumumab 58
D12.776.124.486.485.114.224.060.866 ramucirumab 1
D12.776.124.486.485.114.224.060.868 ranibizumab 61
D12.776.124.486.485.114.224.060.875 trastuzumab 274
D12.776.124.486.485.114.224.060.937 ustekinumab 121
D12.776.124.790 sérové globuliny 61
D12.776.124.790.651 imunoglobuliny 1 492
D12.776.124.790.651.114 protilátky 1 815
D12.776.124.790.651.114.224 monoklonální protilátky 4 659
D12.776.124.790.651.114.224.060 humanizované monoklonální protilátky 2 854
D12.776.124.790.651.114.224.060.125 abciximab 14
D12.776.124.790.651.114.224.060.250 adalimumab 349
D12.776.124.790.651.114.224.060.375 alemtuzumab 125
D12.776.124.790.651.114.224.060.407 basiliximab 2
D12.776.124.790.651.114.224.060.438 bevacizumab 452
D12.776.124.790.651.114.224.060.469 brentuximab vedotin 42
D12.776.124.790.651.114.224.060.500 certolizumab pegol 47
D12.776.124.790.651.114.224.060.750 cetuximab 186
D12.776.124.790.651.114.224.060.766 daklizumab 6
D12.776.124.790.651.114.224.060.782 denosumab 153
D12.776.124.790.651.114.224.060.790 gemtuzumab 16
D12.776.124.790.651.114.224.060.794 inotuzumab ozogamicin 12
D12.776.124.790.651.114.224.060.798 ipilimumab 263
D12.776.124.790.651.114.224.060.813 natalizumab 157
D12.776.124.790.651.114.224.060.829 nivolumab 449
D12.776.124.790.651.114.224.060.844 omalizumab 112
D12.776.124.790.651.114.224.060.860 palivizumab 12
D12.776.124.790.651.114.224.060.864 panitumumab 58
D12.776.124.790.651.114.224.060.866 ramucirumab 1
D12.776.124.790.651.114.224.060.868 ranibizumab 61
D12.776.124.790.651.114.224.060.875 trastuzumab 274
D12.776.124.790.651.114.224.060.937 ustekinumab 121
D12.776.377 globuliny 68
D12.776.377.715 sérové globuliny 61
D12.776.377.715.548 imunoglobuliny 1 492
D12.776.377.715.548.114 protilátky 1 815
D12.776.377.715.548.114.224 monoklonální protilátky 4 659
D12.776.377.715.548.114.224.200 humanizované monoklonální protilátky 2 854
D12.776.377.715.548.114.224.200.125 abciximab 14
D12.776.377.715.548.114.224.200.250 adalimumab 349
D12.776.377.715.548.114.224.200.375 alemtuzumab 125
D12.776.377.715.548.114.224.200.407 basiliximab 2
D12.776.377.715.548.114.224.200.438 bevacizumab 452
D12.776.377.715.548.114.224.200.469 brentuximab vedotin 42
D12.776.377.715.548.114.224.200.500 certolizumab pegol 47
D12.776.377.715.548.114.224.200.750 cetuximab 186
D12.776.377.715.548.114.224.200.766 daklizumab 6
D12.776.377.715.548.114.224.200.782 denosumab 153
D12.776.377.715.548.114.224.200.790 gemtuzumab 16
D12.776.377.715.548.114.224.200.794 inotuzumab ozogamicin 12
D12.776.377.715.548.114.224.200.798 ipilimumab 263
D12.776.377.715.548.114.224.200.813 natalizumab 157
D12.776.377.715.548.114.224.200.829 nivolumab 449
D12.776.377.715.548.114.224.200.844 omalizumab 112
D12.776.377.715.548.114.224.200.860 palivizumab 12
D12.776.377.715.548.114.224.200.864 panitumumab 58
D12.776.377.715.548.114.224.200.866 ramucirumab 1
D12.776.377.715.548.114.224.200.868 ranibizumab 61
D12.776.377.715.548.114.224.200.875 trastuzumab 274
D12.776.377.715.548.114.224.200.937 ustekinumab 121

Přidat